12 days ago
GH
AnalystsMark MassaroMark Massaro's Stock Forecasts
AnalystsMark Massaro
Analyst Ranking
Top 10%
#509 out of 5158 analysts
Average Return
+10.58%
Win Rate
49%80 out of 162
Risk vs Reward
Poor
Good
Mark Massaro's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Genedx Holdings CorpWGS | +776.23% | $10.39 | $91.04 | 2024-04-21 - 2025-04-21 | Strong Buy |
Genedx Holdings CorpWGS | +585.24% | $17.07 | $116.97 | 2024-04-29 - 2025-04-29 | Strong Buy |
Genedx Holdings CorpWGS | +239.56% | $26.19 | $88.93 | 2024-06-25 - 2025-06-25 | Strong Buy |
Genedx Holdings CorpWGS | +216.35% | $32.72 | $103.51 | 2024-07-30 - 2025-07-30 | Strong Buy |
Adaptive Biotechnologies CorpADPT | +183.27% | $5.14 | $14.56 | 2024-10-01 - 2025-10-01 | Strong Buy |
Mark Massaro Analyst Color
Get additional color on Mark Massaro's coverage of popular stocks
12 days ago
WGS
12 days ago
CSTL
a month ago
TEM
a month ago
MDXH
a month ago
XGN
a month ago
SOPH
2 months ago
NTRA
2 months ago
EXAS
2 months ago
IDXX
2 months ago
GH
2 months ago
WGS
2 months ago
NTRA
3 months ago
GH
4 months ago
LUCD
4 months ago
GH
4 months ago
TEM
a year ago
ADPT
a year ago
EXAS
2 years ago
BNGO
3 years ago
MDXH
3 years ago
DNA
3 years ago
MXCT
Mark Massaro's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mdxhealth SaMDXH | 9 | Strong Buy | $7.00 | +101.73% | Reiterates | a day ago |
Guardant Health IncGH | 7 | Strong Buy | $140.00 | +36.59% | Maintains | 12 days ago |
Genedx Holdings CorpWGS | 9 | Strong Buy | $200.00 | +47.77% | Maintains | 12 days ago |
Castle Biosciences IncCSTL | 4 | Strong Buy | $50.00 | +24.38% | Maintains | 12 days ago |
Billiontoone IncBLLN | 2 | Strong Buy | $160.00 | +83.75% | Reiterates | 14 days ago |
Natera IncNTRA | 11 | Strong Buy | $260.00 | +10.45% | Maintains | 19 days ago |
Zoetis IncZTS | 4 | Strong Buy | $160.00 | +29.51% | Reiterates | 21 days ago |
Tempus Ai IncTEM | 6 | Strong Buy | $105.00 | +62.24% | Maintains | a month ago |
Personalis IncPSNL | 3 | Strong Buy | $12.00 | +42.52% | Maintains | a month ago |
Exagen IncXGN | 5 | Strong Buy | $15.00 | +137.34% | Maintains | a month ago |
Sophia Genetics SaSOPH | 3 | Strong Buy | $7.00 | +50.21% | Maintains | a month ago |
Caredx IncCDNA | 5 | Strong Buy | $25.00 | +24.88% | Maintains | 2 months ago |
Adaptive Biotechnologies CorpADPT | 6 | Strong Buy | $21.00 | +25.37% | Maintains | 2 months ago |
Exact Sciences CorpEXAS | 17 | Strong Buy | $85.00 | -16.33% | Maintains | 2 months ago |
Idexx Laboratories IncIDXX | 2 | Strong Buy | $830.00 | +21.65% | Maintains | 2 months ago |
Lucid Diagnostics IncLUCD | 4 | Strong Buy | $2.50 | +127.27% | Reiterates | 3 months ago |
Ginkgo Bioworks Holdings IncDNA | 4 | Strong Sell | $9.00 | +2.62% | Maintains | 4 months ago |
Bionano Genomics IncBNGO | 7 | Strong Buy | $120.00 | N/A | Maintains | 2 years ago |
Akoya Biosciences IncAKYA | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Neogenomics IncNEO | 4 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Maxcyte IncMXCT | 3 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Dermtech IncDMTKQ | 4 | Strong Buy | $2.00 | N/A | Maintains | 2 years ago |
Talis Biomedical CorpTLIS | 3 | Strong Sell | $5.00 | N/A | Maintains | 2 years ago |
Cue Health IncHLTHQ | 4 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Renalytix PLCRNLXY | 3 | Strong Buy | $3.50 | N/A | Maintains | 3 years ago |
Lumiradx LtdLMDXF | 1 | Strong Buy | $4.00 | N/A | Maintains | 3 years ago |
Phenomex IncCELL | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
T2 Biosystems IncTTOO | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Quotient LtdQTNTQ | 1 | Strong Buy | $1.50 | N/A | Maintains | 3 years ago |
Insight Molecular Diagnostics IncIMDX | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 5 years ago |
Chembio Diagnostics IncCEMI | 1 | Strong Buy | $12.00 | N/A | Maintains | 6 years ago |
Labcorp Holdings IncLH | 4 | Hold | $155.00 | N/A | Maintains | 7 years ago |
Genmark Diagnostics IncGNMK | 4 | Strong Buy | $9.00 | N/A | Maintains | 7 years ago |
Quest Diagnostics IncDGX | 3 | Strong Buy | $105.00 | N/A | Maintains | 7 years ago |
Hologic IncHOLX | 3 | Hold | $41.00 | N/A | Maintains | 7 years ago |
Quidelortho CorpQDEL | 4 | Strong Buy | $80.00 | N/A | Maintains | 7 years ago |
Genomic Health IncGHDX | 3 | Strong Buy | $62.00 | N/A | Maintains | 7 years ago |
Illumina IncILMN | 3 | Strong Buy | $340.00 | N/A | Maintains | 7 years ago |
Heska CorpHSKA | 2 | Strong Buy | $123.00 | N/A | Maintains | 8 years ago |
Htg Molecular Diagnostics IncHTGMQ | 2 | Strong Buy | $1,260.00 | N/A | Maintains | 8 years ago |
Abaxis IncABAX | 1 | Hold | $47.00 | N/A | Maintains | 8 years ago |
Alere IncALR1 | 4 | Hold | $56.00 | N/A | Downgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.